Smith-Lemli-Opitz Screen, Pl




Test Mnemonic

SLOSCN

CPT Codes

  • 82542 - QTY (1)

Aliases

  • 7-Dehydrocholesterol
  • Smith Lemli Opitz

Performing Laboratory

Kennedy Krieger Institute


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLPlasmaSodium or Lithium heparin (Green) FrozenCentrifuge, aliquot and freeze ASAP.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLPlasmaEDTA (Lavender) FrozenCentrifuge, aliquot and freeze ASAP.

Stability

Environmental Condition Description
AmbientUnacceptable
RefrigeratedUnacceptable
FrozenIndefinitely

Days Performed

Tue - Fri

Turnaround Time

4 - 7 days

Methodology

Name Description
Gas Chromatography Mass Spectrometry (GCMS) 

Reference Range

Smith-Lemli-Opitz Screen, Pl
Sex Age From Age To Type Range Range Unit
       Normal0.04 - 0.36ug/mL

Special Info

Centrifuge, aliquot and freeze ASAP.

Clinical Info

Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency) is an autosomal recessive disorder characterized by markedly increased plasma concentrations of 7-dehydrocholesterol (7-DHC) and 8-DHC levels. Severity ranges from mild to severe. Clinical features include microcephaly, growth retardation, developmental delay, dysmorphic facial features, limb abnormalities (especially syndactyly and polydactyly of the toes), and heart and kidney malfunctions. The estimated incidence is between 1:10,000 and 1:60,000. Elevated plasma concentrations of 7- and 8-DHC are highly suggestive of a biochemical diagnosis of Smith-Lemli-Opitz (SLO). Mild elevations of these cholesterol precursors can be detected in patients with hypercholesterolemia and in patients treated with haloperidol. However, the 7-DHC to cholesterol ratio is only elevated in SLO patients.